In another study of 178 patients from the SUSTAIN 8 trial on semaglutide, the average proportion of lean mass loss was nearly identical at 40% (1)
This is what all the trials are showing us. But barriers to accessing these medications remain
Exposure to viruses, bacteria, radiation, environmental toxins, and pollution may deplete glutathione levels, resulting in a buildup of free radicals, which are unstable atoms that can be extremely harmful to the body (Lang et al., 1992)
A deficiency in vitamin C can lead to weak, brittle strands and slower growth
Matched patients included 279,064 patients on GLP-1 drugs and 279,064 on a DPP-4 inhibitor
If you are losing weight steadily, these are worth checking periodically so a slow decline does not sneak up on you